IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.37B
1-Year Est. Return
69.45%
1 Year Est. Return
+69.45%
AUM
$1.37B
AUM Growth
+$301M
(+28%)
Holding
90
Top Buys
| 1 | +$22M | |
| 2 | +$20.9M | |
| 3 | +$16M | |
| 4 |
Centene
CNC
|
+$14.3M |
| 5 |
Doximity
DOCS
|
+$13.2M |
Top Sells
| 1 | +$45.5M | |
| 2 | +$43.8M | |
| 3 | +$24.4M | |
| 4 |
DexCom
DXCM
|
+$17.5M |
| 5 |
Encompass Health
EHC
|
+$15.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$41.4B
| $230M | 15.59% |
1,600,000
|
|
||
2
Cytokinetics
CYTK
$7.53B
| $76.9M | 5.21% |
1,400,000
+400,000
|
|
||
3
Tenet Healthcare
THC
$17.8B
| $60.9M | 4.12% |
300,000
+25,000
|
|
||
4
Mineralys Therapeutics
MLYS
$2.91B
| $56.9M | 3.85% |
1,500,000
-1,200,000
|
|
||
5
Vera Therapeutics
VERA
$2.86B
| $49.4M | 3.34% |
1,700,000
+550,000
|
|
||
6
uniQure
QURE
$1.29B
| $35M | 2.37% |
600,000
-750,000
|
|
||
7
BrightSpring Health Services
BTSG
$6.39B
| $34M | 2.3% |
1,150,000
-100,000
|
|
||
8
Boston Scientific
BSX
$137B
| $29.3M | 1.98% |
300,000
-250,000
|
|
||
9
Regeneron Pharmaceuticals
REGN
$72.8B
| $28.1M | 1.9% |
50,000
|
|
||
10
Alignment Healthcare
ALHC
$3.84B
| $27.9M | 1.89% |
1,600,000
+1,200,000
|
|
||
11
Alnylam Pharmaceuticals
ALNY
$54.9B
| $27.4M | 1.85% |
60,000
+5,000
|
|
||
12
Novartis
NVS
$251B
| $25.6M | 1.74% |
200,000
|
|
||
|
13
Encompass Health
EHC
$10.9B
| $25.4M | 1.72% |
200,000
-120,000
|
|
||
14
Edgewise Therapeutics
EWTX
$2.47B
| $24.3M | 1.65% |
1,500,000
+500,000
|
|
||
15
AstraZeneca
AZN
$278B
| $23M | 1.56% |
300,000
+100,000
|
|
||
16
RadNet
RDNT
$5.86B
| $22.9M | 1.55% |
300,000
-100,000
|
|
||
17
Rhythm Pharmaceuticals
RYTM
$6.72B
| $22.2M | 1.5% |
220,000
+100,000
|
|
||
18
Neurocrine Biosciences
NBIX
$15.5B
| $21.1M | 1.42% |
150,000
|
|
||
19
Cardinal Health
CAH
$47B
| $20.4M | 1.38% |
130,000
-10,000
|
|
||
20
Rezolute
RZLT
$913M
| $18.8M | 1.27% |
2,000,000
+200,000
|
|
||
21
Revolution Medicines
RVMD
$15B
| $18.7M | 1.26% |
400,000
+75,000
|
|
||
22
Quest Diagnostics
DGX
$20B
| $16.2M | 1.1% |
85,000
-65,000
|
|
||
23
Elevance Health
ELV
$73.3B
| $16.2M | 1.09% |
50,000
-10,000
|
|
||
24
Elanco Animal Health
ELAN
$10.2B
| $16.1M | 1.09% |
800,000
+450,000
|
|
||
25
Edwards Lifesciences
EW
$48.3B
| $15.6M | 1.05% |
200,000
|
|